Calumet Reports Second Quarter 2024 Results
Calumet reported Q2 2024 results with a net loss of $39.1 million and Adjusted EBITDA of $66.8 million. Key highlights include:
- Successful conversion from MLP to C-Corp structure
- Montana Renewables achieved full production, producing ~7 million gallons of SAF
- Record volumes in Specialties and Renewables businesses
- Specialty Products and Solutions Adjusted EBITDA: $65.8 million
- Performance Brands Adjusted EBITDA: $14.1 million
- Montana/Renewables Adjusted EBITDA: $7.6 million
CEO Todd Borgmann noted strong operational performance in specialties and renewables, progress on DOE discussions for MaxSAF expansion, and focus on creating shareholder value. The company expects the C-Corp conversion to increase its shareholder base over time.
Calumet ha riportato i risultati del Q2 2024 con una perdita netta di 39,1 milioni di dollari e un EBITDA rettificato di 66,8 milioni di dollari. I punti salienti includono:
- Successosa conversione da struttura MLP a C-Corp
- Montana Renewables ha raggiunto la piena produzione, producendo circa 7 milioni di galloni di SAF
- Volumi record nel settore Specialties e Renewables
- EBITDA rettificato per Specialty Products and Solutions: 65,8 milioni di dollari
- EBITDA rettificato per Performance Brands: 14,1 milioni di dollari
- EBITDA rettificato per Montana/Renewables: 7,6 milioni di dollari
Il CEO Todd Borgmann ha sottolineato il forte rendimento operativo nel settore delle specialità e delle energie rinnovabili, i progressi nei colloqui con il DOE per l'espansione di MaxSAF, e l'attenzione nella creazione di valore per gli azionisti. L'azienda si aspetta che la conversione in C-Corp aumenti nel tempo la sua base di azionisti.
Calumet reportó resultados del Q2 2024 con una pérdida neta de 39,1 millones de dólares y un EBITDA ajustado de 66,8 millones de dólares. Los puntos destacados incluyen:
- Conversión exitosa de MLP a estructura C-Corp
- Montana Renewables logró producción completa, produciendo aproximadamente 7 millones de galones de SAF
- Volúmenes récord en los negocios de Especialidades y Energías Renovables
- EBITDA ajustado de Productos y Soluciones Especializadas: 65,8 millones de dólares
- EBITDA ajustado de Marcas de Rendimiento: 14,1 millones de dólares
- EBITDA ajustado de Montana/Energías Renovables: 7,6 millones de dólares
El CEO Todd Borgmann destacó el sólido rendimiento operativo en especialidades y energías renovables, el progreso en las discusiones con el DOE para la expansión de MaxSAF, y el enfoque en crear valor para los accionistas. La empresa espera que la conversión a C-Corp aumente su base de accionistas con el tiempo.
Calumet는 2024년 2분기 결과를 보고하며 3,910만 달러의 순손실과 6,680만 달러의 조정 EBITDA를 기록했습니다. 주요 하이라이트는 다음과 같습니다:
- MLP에서 C-Corp 구조로의 성공적인 전환
- 몬태나 재생 가능 에너지는 전체 생산에 도달하여 약 700만 갤런의 SAF를 생산했습니다.
- 특수 및 재생 에너지 사업에서 기록적인 물량 달성
- 특수 제품 및 솔루션 조정 EBITDA: 6,580만 달러
- 성과 브랜드 조정 EBITDA: 1,410만 달러
- 몬태나/재생 가능 에너지 조정 EBITDA: 760만 달러
CEO인 Todd Borgmann은 특수 및 재생 에너지 분야에서의 강력한 운영 성과와 MaxSAF 확장을 위한 DOE와의 논의 진행 상황, 주주 가치를 창출하기 위한 집중을 강조했습니다. 회사는 C-Corp 전환이 시간이 지남에 따라 주주 기반을 증가시킬 것으로 기대하고 있습니다.
Calumet a annoncé les résultats du 2ème trimestre 2024 avec une perte nette de 39,1 millions de dollars et un EBITDA ajusté de 66,8 millions de dollars. Les principaux points saillants comprennent :
- Conversion réussie de la structure MLP en C-Corp
- Montana Renewables a atteint une production complète, produisant environ 7 millions de gallons de SAF
- Volumes records dans les activités Spécialités et Énergies Renouvelables
- EBITDA ajusté des Produits et Solutions Spécialisés : 65,8 millions de dollars
- EBITDA ajusté des Marques de Performance : 14,1 millions de dollars
- EBITDA ajusté de Montana/Renewables : 7,6 millions de dollars
Le PDG Todd Borgmann a souligné la forte performance opérationnelle dans les spécialités et les énergies renouvelables, les progrès des discussions avec le DOE pour l'expansion de MaxSAF, et l'accent mis sur la création de valeur pour les actionnaires. L'entreprise s'attend à ce que la conversion en C-Corp augmente sa base d'actionnaires au fil du temps.
Calumet berichtete über die Ergebnisse des Q2 2024 mit einem Nettoverlust von 39,1 Millionen Dollar und einem bereinigten EBITDA von 66,8 Millionen Dollar. Die wichtigsten Highlights umfassen:
- Erfolgreiche Umstellung von einer MLP- zu einer C-Corp-Struktur
- Montana Renewables erreichte die volle Produktion und produzierte ca. 7 Millionen Gallonen SAF
- Rekordmengen in den Bereichen Spezialitäten und erneuerbare Energien
- Bereinigtes EBITDA für Specialty Products and Solutions: 65,8 Millionen Dollar
- Bereinigtes EBITDA für Performance Brands: 14,1 Millionen Dollar
- Bereinigtes EBITDA für Montana/Renewables: 7,6 Millionen Dollar
CEO Todd Borgmann bemerkte, dass die operative Leistung in den Bereichen Spezialitäten und erneuerbare Energien stark war, Fortschritte in den Gesprächen mit dem DOE zur Erweiterung von MaxSAF erzielt wurden und der Fokus auf der Schaffung von Aktionärswert liegt. Das Unternehmen erwartet, dass die Umstellung auf C-Corp die Aktionärsbasis im Laufe der Zeit erhöhen wird.
- Montana Renewables achieved full production levels, producing ~7 million gallons of SAF
- Record volumes achieved in both Specialties and Renewables businesses
- Specialty Products and Solutions Adjusted EBITDA increased to $65.8 million from $61.0 million year-over-year
- Performance Brands Adjusted EBITDA grew to $14.1 million from $12.2 million year-over-year
- Performance Brands segment saw 30% growth in year-over-year volumes
- Successful completion of conversion from MLP to C-Corp structure
- Q2 2024 net loss of $39.1 million, compared to $22.3 million loss in Q2 2023
- partners' interest basic net loss per unit increased to $0.48 from $0.27 year-over-year
- Montana/Renewables Adjusted EBITDA decreased to $7.6 million from $13.0 million year-over-year
- Corporate costs increased to $20.7 million from $18.1 million in Q2 2023
Insights
Calumet's Q2 2024 results present a mixed picture. The company reported a net loss of
Key positives include record production volumes in Specialties and Renewables and Montana Renewables achieving full production levels. The Specialty Products and Solutions segment saw improved Adjusted EBITDA of
However, the Montana/Renewables segment's Adjusted EBITDA declined to
Calumet's Q2 results reflect the complex dynamics in the specialty products and renewable fuels markets. The record volumes in Specialties and Renewables suggest strong demand, but the widening net loss indicates challenges in profitability, possibly due to cost pressures or pricing issues.
The Performance Brands segment's
The company's focus on SAF (Sustainable Aviation Fuel) production and the planned MaxSAF expansion align with growing trends in sustainable transportation. However, investors should monitor the progress of DOE discussions and potential funding, as this could significantly impact future growth prospects and capital expenditure requirements.
Calumet's renewable energy segment shows promising developments, particularly in Sustainable Aviation Fuel (SAF) production. The Montana Renewables facility achieved full production levels, producing approximately 7 million gallons of SAF in Q2. This is significant given the growing demand for SAF in the aviation industry's decarbonization efforts.
The planned MaxSAF expansion, pending DOE discussions, could position Calumet as a major player in the SAF market. However, the decrease in Montana/Renewables Adjusted EBITDA to
The company's target to reduce costs to
- Second quarter 2024 net loss of
$39.1 million $0.48 - Second quarter 2024 Adjusted EBITDA of
$66.8 million - Successfully completed conversion of structure from a Master Limited Partnership ("MLP") to a C-Corp
- Montana Renewables ("MRL") achieved full production levels for the second quarter; produced approximately 7 million gallons of SAF
- Record volumes achieved in both Specialties and Renewables businesses
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
(Dollars in millions, except per unit data) | ||||||||||||
Net loss | $ | (39.1) | $ | (22.3) | $ | (80.7) | $ | (3.7) | ||||
Limited partners' interest basic net loss per unit | $ | (0.48) | $ | (0.27) | $ | (0.98) | $ | (0.05) | ||||
Adjusted EBITDA | $ | 66.8 | $ | 68.1 | $ | 88.4 | $ | 145.4 | ||||
Specialty Products and Solutions | Performance Brands | |||||||||||||||||
Three Months Ended June 30, | Three Months Ended June 30, | Three Months Ended June 30, | ||||||||||||||||
2024 | 2023 | 2024 | 2023 | 2024 | 2023 | |||||||||||||
(Dollars in millions, except per barrel data) | ||||||||||||||||||
Gross profit (loss) | $ | 39.1 | $ | 45.3 | $ | 25.1 | $ | 21.4 | $ | (0.4) | $ | 4.8 | ||||||
Adjusted gross profit | $ | 66.0 | $ | 68.3 | $ | 25.4 | $ | 22.6 | $ | 18.8 | $ | 19.3 | ||||||
Adjusted EBITDA | $ | 65.8 | $ | 61.0 | $ | 14.1 | $ | 12.2 | $ | 7.6 | $ | 13.0 | ||||||
Gross profit (loss) per barrel | $ | 6.71 | $ | 8.55 | $ | 141.01 | $ | 153.96 | $ | (0.18) | $ | 2.70 | ||||||
Adjusted gross profit per barrel | $ | 11.32 | $ | 12.90 | $ | 142.70 | $ | 162.59 | $ | 8.53 | $ | 10.85 | ||||||
Specialty Products and Solutions | Performance Brands | |||||||||||||||||
Six Months Ended June 30, | Six Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||
2024 | 2023 | 2024 | 2023 | 2024 | 2023 | |||||||||||||
(Dollars in millions, except per barrel data) | ||||||||||||||||||
Gross profit (loss) | $ | 124.4 | $ | 155.2 | $ | 47.4 | $ | 45.0 | $ | (29.5) | $ | (32.1) | ||||||
Adjusted gross profit | $ | 117.4 | $ | 167.1 | $ | 48.6 | $ | 43.4 | $ | 12.8 | $ | 30.9 | ||||||
Adjusted EBITDA | $ | 107.6 | $ | 137.0 | $ | 27.5 | $ | 28.6 | $ | (6.9) | $ | 17.8 | ||||||
Gross profit (loss) per barrel | $ | 11.07 | $ | 14.82 | $ | 147.20 | $ | 169.17 | $ | (6.92) | $ | (9.47) | ||||||
Adjusted gross profit per barrel | $ | 10.45 | $ | 15.95 | $ | 150.93 | $ | 163.16 | $ | 3.00 | $ | 9.12 | ||||||
"Calumet benefited from a strong operational quarter as we continue to demonstrate the strength of our specialties and renewables businesses," said Todd Borgmann, CEO. "As planned, Montana Renewables produced at full rates throughout the quarter, achieving record levels of throughput, pretreater utilization, SAF production, and Adjusted EBITDA all while continuing to decrease costs towards our
"In addition, our advanced discussions with the DOE continue to progress well, and we look forward to launching our planned MaxSAF expansion. MaxSAF is a world-class project, which is aligned with strategic national interest in one of the fastest growing segments in energy. Finally, in July, we were pleased to complete our C-Corp conversion, and we expect this to meaningfully increase our shareholder base over time. We remain aggressively focused on executing our strategic plans to create substantial shareholder value."
Specialty Products and Solutions (SPS): The SPS segment reported Adjusted EBITDA of
Performance Brands (PB): The PB segment reported Adjusted EBITDA of
Corporate: Total corporate costs represent
Calumet Specialty Products Partners, L.P. Completes Conversion to C-Corporation: As previously announced, Calumet Specialty Products Partners, L.P. completed the previously announced conversion (the "Conversion") of its structure from an MLP to a C-Corporation, pursuant to which the unitholders of the Partnership became shareholders of Calumet, Inc. As previously announced, at the Partnership's special meeting of unitholders held on July 9, 2024, over
Operations Summary
The following table sets forth information about the Partnership's continuing operations. Facility production volume differs from sales volume due to changes in inventories and the sale of purchased blendstocks such as ethanol and specialty blendstocks, as well as the resale of crude oil.
Three Months Ended June 30, | Six Months Ended June 30, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
(In bpd) | (In bpd) | |||||||
Total sales volume (1) | 90,242 | 79,266 | 86,922 | 78,071 | ||||
Total feedstock runs (2) | 86,254 | 74,383 | 78,901 | 72,979 | ||||
Facility production: (3) | ||||||||
Specialty Products and Solutions: | ||||||||
Lubricating oils | 12,266 | 10,495 | 11,727 | 10,396 | ||||
Solvents | 7,797 | 6,053 | 7,488 | 7,181 | ||||
Waxes | 1,660 | 1,314 | 1,534 | 1,344 | ||||
Fuels, asphalt and other by-products | 39,690 | 36,093 | 35,802 | 35,288 | ||||
Total Specialty Products and Solutions | 61,413 | 53,955 | 56,551 | 54,209 | ||||
Gasoline | 3,501 | 3,662 | 3,524 | 4,032 | ||||
Diesel | 2,905 | 3,105 | 2,804 | 2,879 | ||||
Jet fuel | 713 | 392 | 534 | 450 | ||||
Asphalt, heavy fuel oils and other | 4,076 | 4,728 | 4,112 | 4,480 | ||||
Renewable fuels | 11,797 | 7,312 | 10,020 | 6,177 | ||||
Total | 22,992 | 19,199 | 20,994 | 18,018 | ||||
Performance Brands | 1,895 | 1,459 | 1,739 | 1,528 | ||||
Total facility production (3) | 86,300 | 74,613 | 79,284 | 73,755 | ||||
__________________
(1) | Total sales volume includes sales from the production at our facilities and certain third-party facilities pursuant to supply and/or processing agreements, sales of inventories and the resale of crude oil to third-party customers. Total sales volume includes the sale of purchased blendstocks. |
(2) | Total feedstock runs represent the barrels per day of crude oil and other feedstocks processed at our facilities and at certain third-party facilities pursuant to supply and/or processing agreements. |
(3) | The difference between total facility production and total feedstock runs is primarily a result of the time lag between the input of feedstocks and production of finished products and volume loss. |
Webcast Information
A conference call is scheduled for 9:00 a.m. ET on August 9, 2024 to discuss the financial and operational results for the second quarter of 2024. Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides, available on Calumet's website at www.calumet.investorroom.com/events. Interested parties may also participate in the call by dialing (844) 695-5524. A replay of the conference call will be available a few hours after the event on the investor relations section of Calumet's website, under the events and presentations section and will remain available for at least 90 days.
About Calumet
Calumet, Inc. (NASDAQ: CLMT) manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. Calumet is headquartered in
Cautionary Statement Regarding Forward-Looking Statements
Certain statements and information in this press release may constitute "forward-looking statements." The words "will," "may," "intend," "believe," "expect," "outlook," "forecast," "anticipate," "estimate," "continue," "plan," "should," "could," "would," or other similar expressions are intended to identify forward-looking statements, which are generally not historical in nature. The statements discussed in this press release that are not purely historical data are forward-looking statements, including, but not limited to, the statements regarding (i) demand for finished products in markets we serve, (ii) our expectation regarding our business outlook and cash flows, including with respect to the Montana Renewables business and our plans to de-leverage our balance sheet, (iii) our expectation regarding anticipated capital expenditures and strategic initiatives, and (iv) our ability to meet our financial commitments, debt service obligations, debt instrument covenants, contingencies and anticipated capital expenditures. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting us will be those that we anticipate. All comments concerning our current expectations for future sales and operating results are based on our forecasts for our existing operations and do not include the potential impact of any future acquisition or disposition transactions. Our forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause our actual results to differ materially from our historical experience and our present expectations or projections. Known material factors that could cause actual results to differ materially from those in the forward-looking statements include: the overall demand for specialty products, fuels, renewable fuels and other refined products; the level of foreign and domestic production of crude oil and refined products; our ability to produce specialty products, fuel products, and renewable fuel products that meet our customers' unique and precise specifications; the marketing of alternative and competing products; the impact of fluctuations and rapid increases or decreases in crude oil and crack spread prices, including the resulting impact on our liquidity; the results of our hedging and other risk management activities; our ability to comply with financial covenants contained in our debt instruments; the availability of, and our ability to consummate, acquisition or combination opportunities and the impact of any completed acquisitions; labor relations; our access to capital to fund expansions, acquisitions and our working capital needs and our ability to obtain debt or equity financing on satisfactory terms; successful integration and future performance of acquired assets, businesses or third-party product supply and processing relationships; our ability to timely and effectively integrate the operations of acquired businesses or assets, particularly those in new geographic areas or in new lines of business; environmental liabilities or events that are not covered by an indemnity, insurance or existing reserves; maintenance of our credit ratings and ability to receive open credit lines from our suppliers; demand for various grades of crude oil and resulting changes in pricing conditions; fluctuations in refinery capacity; our ability to access sufficient crude oil supply through long-term or month-to-month evergreen contracts and on the spot market; the effects of competition; continued creditworthiness of, and performance by, counterparties; the impact of current and future laws, rulings and governmental regulations, including guidance related to the Dodd-Frank Wall Street Reform and Consumer Protection Act; the costs of complying with the Renewable Fuel Standard, including the prices paid for renewable identification numbers ("RINs"); shortages or cost increases of power supplies, natural gas, materials or labor; hurricane or other weather interference with business operations; our ability to access the debt and equity markets; accidents or other unscheduled shutdowns; and general economic, market, business or political conditions, including inflationary pressures, instability in financial institutions, general economic slowdown or a recession, political tensions, conflicts and war (such as the ongoing conflicts in
For additional information regarding factors that could cause our actual results to differ from our projected results, please see our filings with the SEC, including the risk factors and other cautionary statements in our latest Annual Report on Form 10-K and other filings with the SEC by us and Calumet, Inc.
We caution that these statements are not guarantees of future performance and you should not rely unduly on them, as they involve risks, uncertainties, and assumptions that we cannot predict. In addition, we have based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. While our management considers these assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond our control. Accordingly, our actual results may differ materially from the future performance that we have expressed or forecast in our forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required by applicable law. Certain public statements made by us and our representatives on the date hereof may also contain forward-looking statements, which are qualified in their entirety by the cautionary statements contained above.
Non-GAAP Financial Measures
Our management uses certain non-GAAP performance measures to analyze operating segment performance and non-GAAP financial measures to evaluate past performance and prospects for the future to supplement our financial information presented in accordance with generally accepted accounting principles ("GAAP"). These financial and operational non-GAAP measures are important factors in assessing our operating results and profitability and include performance measures along with certain key operating metrics.
We use the following financial performance measures:
EBITDA: We define EBITDA for any period as net income (loss) plus interest expense (including amortization of debt issuance costs), income taxes and depreciation and amortization. Historically, we considered net income (loss) to be the most directly comparable GAAP measure to EBITDA. We believe net income (loss) is the most directly comparable GAAP measure to EBITDA.
Adjusted EBITDA: We define Adjusted EBITDA for any period as: EBITDA adjusted for (a) impairment; (b) unrealized gains and losses from mark to market accounting for hedging activities; (c) realized gains and losses under derivative instruments excluded from the determination of net income (loss); (d) non-cash equity-based compensation expense and other non-cash items (excluding items such as accruals of cash expenses in a future period or amortization of a prepaid cash expense) that were deducted in computing net income (loss); (e) debt refinancing fees, extinguishment costs, premiums and penalties; (f) any net gain or loss realized in connection with an asset sale that was deducted in computing net income (loss); (g) amortization of turnaround costs; (h) LCM inventory adjustments; (i) the impact of liquidation of inventory layers calculated using the LIFO method; (j) RINs mark-to-market adjustments; and (k) all extraordinary, unusual or non-recurring items of gain or loss, or revenue or expense.
Distributable Cash Flow: We define Distributable Cash Flow for any period as Adjusted EBITDA less replacement and environmental capital expenditures, turnaround costs, cash interest expense (consolidated interest expense less non-cash interest expense), gain (loss) from unconsolidated affiliates, net of cash distributions and income tax expense (benefit).
Specialty Products and Solutions segment Adjusted EBITDA Margin: We define Specialty Products and Solutions segment Adjusted EBITDA Margin for any period as Specialty Products and Solutions segment Adjusted EBITDA divided by Specialty Products and Solutions segment sales.
Specialty Products and Solutions segment Adjusted gross profit (loss): We define Specialty Products and Solutions segment Adjusted gross profit (loss) for any period as Specialty Products and Solutions segment gross profit (loss) excluding the impact of (a) LCM inventory adjustments; (b) the impact of liquidation of inventory layers calculated using the LIFO method; (c) RINs mark-to-market adjustments; (d) depreciation and amortization; and (e) all extraordinary, unusual or non-recurring items of revenue or cost of sales.
Performance Brands segment Adjusted gross profit (loss): We define Performance Brands segment Adjusted gross profit (loss) for any period as Performance Brands segment gross profit (loss) excluding the impact of (a) LCM inventory adjustments; (b) the impact of liquidation of inventory layers calculated using the LIFO method; (c) RINs mark-to-market adjustments; (d) depreciation and amortization; and (e) all extraordinary, unusual or non-recurring items of revenue or cost of sales.
The definition of Adjusted EBITDA that is presented in this press release is similar to the calculation of (i) "Consolidated Cash Flow" contained in the indentures governing our
These non-GAAP measures are used as supplemental financial measures by our management and by external users of our financial statements such as investors, commercial banks, research analysts and others, to assess:
- the financial performance of our assets without regard to financing methods, capital structure or historical cost basis;
- the ability of our assets to generate cash sufficient to pay interest costs and support our indebtedness;
- our operating performance and return on capital as compared to those of other companies in our industry, without regard to financing or capital structure;
- the viability of acquisitions and capital expenditure projects and the overall rates of return on alternative investment opportunities; and
- our operating performance excluding the non-cash impact of LCM and LIFO inventory adjustments, RINs mark-to-market adjustments, and depreciation and amortization.
We believe that these non-GAAP measures are useful to analysts and investors, as they exclude transactions not related to our core cash operating activities and provide metrics to analyze our ability to fund our capital requirements and to pay interest on our debt obligations. We believe that excluding these transactions allows investors to meaningfully analyze trends and performance of our core cash operations.
EBITDA, Adjusted EBITDA, Distributable Cash Flow, and segment Adjusted gross profit (loss) should not be considered alternatives to Net income (loss), Operating income (loss), Net cash provided by (used in) operating activities, gross profit (loss) or any other measure of financial performance presented in accordance with GAAP. In evaluating our performance as measured by EBITDA, Adjusted EBITDA, Distributable Cash Flow, and segment Adjusted gross profit (loss) management recognizes and considers the limitations of these measurements. EBITDA and Adjusted EBITDA do not reflect our liabilities for the payment of income taxes, interest expense or other obligations such as capital expenditures. Accordingly, EBITDA, Adjusted EBITDA, Distributable Cash Flow, and segment Adjusted gross profit (loss) are only a few of several measurements that management utilizes. Moreover, our EBITDA, Adjusted EBITDA, Distributable Cash Flow, and segment Adjusted gross profit (loss) may not be comparable to similarly titled measures of another company because all companies may not calculate EBITDA, Adjusted EBITDA, Distributable Cash Flow, and segment Adjusted gross profit (loss) in the same manner. Please see the section of this release entitled "Non-GAAP Reconciliations" for tables that present reconciliations of EBITDA, Adjusted EBITDA, and Distributable Cash Flow to Net income (loss), our most directly comparable GAAP financial performance measure; and segment Adjusted gross profit (loss) to segment gross profit (loss), our most directly comparable GAAP financial performance measure.
CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. | ||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
(As Restated) | (As Restated) | |||||||||||
Sales | $ | 1,133.7 | $ | 1,017.8 | $ | 2,139.5 | $ | 2,055.1 | ||||
Cost of sales | 1,069.9 | 946.3 | 1,997.2 | 1,887.0 | ||||||||
Gross profit | 63.8 | 71.5 | 142.3 | 168.1 | ||||||||
Operating costs and expenses: | ||||||||||||
Selling | 15.1 | 15.5 | 28.8 | 29.0 | ||||||||
General and administrative | 37.5 | 25.7 | 60.8 | 62.8 | ||||||||
Other operating expense | 5.0 | 5.2 | 10.2 | 8.2 | ||||||||
Operating income | 6.2 | 25.1 | 42.5 | 68.1 | ||||||||
Other income (expense) | ||||||||||||
Interest expense | (56.8) | (55.8) | (117.6) | (105.0) | ||||||||
Gain (loss) on derivative instruments | 11.3 | 14.3 | (5.6) | 39.8 | ||||||||
Other income (expense): | 0.7 | (5.5) | 0.7 | (5.7) | ||||||||
Total other expense | (44.8) | (47.0) | (122.5) | (70.9) | ||||||||
Net loss before income taxes | (38.6) | (21.9) | (80.0) | (2.8) | ||||||||
Income tax expense | 0.5 | 0.4 | 0.7 | 0.9 | ||||||||
Net loss | $ | (39.1) | $ | (22.3) | $ | (80.7) | $ | (3.7) | ||||
Allocation of net loss to partners | ||||||||||||
Net loss attributable to partners | $ | (39.1) | $ | (22.3) | $ | (80.7) | $ | (3.7) | ||||
Less: | ||||||||||||
General partner's interest in net loss | (0.8) | (0.5) | (1.6) | (0.1) | ||||||||
Net loss available to limited partners | $ | (38.3) | $ | (21.8) | $ | (79.1) | $ | (3.6) | ||||
Weighted average limited partner units outstanding: | ||||||||||||
Basic and diluted | 80,555,587 | 80,152,648 | 80,453,995 | 79,992,637 | ||||||||
Limited partners' interest basic and diluted net loss per unit: | ||||||||||||
Limited partners' interest | $ | (0.48) | $ | (0.27) | $ | (0.98) | $ | (0.05) | ||||
CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. | ||||||
June 30, 2024 | December 31, 2023 | |||||
ASSETS | (Unaudited) | |||||
Current assets: | ||||||
Cash and cash equivalents | $ | 7.0 | $ | 7.9 | ||
Accounts receivable, net: | ||||||
Trade, less allowance for credit losses of | 306.9 | 252.4 | ||||
Other | 32.7 | 33.8 | ||||
339.6 | 286.2 | |||||
Inventories | 394.8 | 439.4 | ||||
Derivative assets | 3.7 | 9.6 | ||||
Prepaid expenses and other current assets | 50.5 | 51.6 | ||||
Total current assets | 795.6 | 794.7 | ||||
Property, plant and equipment, net | 1,467.2 | 1,506.3 | ||||
Other noncurrent assets, net | 408.1 | 450.3 | ||||
Total assets | $ | 2,670.9 | $ | 2,751.3 | ||
LIABILITIES AND PARTNERS' CAPITAL (DEFICIT) | ||||||
Current liabilities: | ||||||
Accounts payable | $ | 342.3 | $ | 322.0 | ||
Accrued interest payable | 49.5 | 48.7 | ||||
Accrued salaries, wages and benefits | 73.0 | 87.1 | ||||
Obligations under inventory financing agreements | 34.9 | 190.4 | ||||
Current portion of RINs obligation | 232.9 | 277.3 | ||||
Other current liabilities | 97.1 | 131.5 | ||||
Current portion of long-term debt | 390.4 | 55.7 | ||||
Total current liabilities | 1,220.1 | 1,112.7 | ||||
Other long-term liabilities | 146.5 | 53.6 | ||||
Long-term debt, less current portion | 1,625.1 | 1,829.7 | ||||
Total liabilities | $ | 2,991.7 | $ | 2,996.0 | ||
Commitments and contingencies | ||||||
Redeemable noncontrolling interest | $ | 245.6 | $ | 245.6 | ||
Partners' capital (deficit): | ||||||
Limited partners' interest (80,388,555 units and 79,967,363 units, issued and | $ | (559.0) | $ | (484.4) | ||
General partner's interest | (0.3) | 1.3 | ||||
Accumulated other comprehensive loss | (7.1) | (7.2) | ||||
Total partners' capital (deficit) | (566.4) | (490.3) | ||||
Total liabilities and partners' capital (deficit) | $ | 2,670.9 | $ | 2,751.3 | ||
CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In millions) | ||||||
Six Months Ended June 30, | ||||||
2024 | 2023 | |||||
(As Restated) | ||||||
Operating activities | ||||||
Net loss | $ | (80.7) | $ | (3.7) | ||
Non-cash RINs (gain) expense | (44.4) | 23.4 | ||||
Unrealized (gain) loss on derivative instruments | 14.6 | (55.1) | ||||
Other non-cash activities | 84.5 | 100.7 | ||||
Changes in assets and liabilities | (1.5) | (117.9) | ||||
Net cash used in operating activities | $ | (27.5) | $ | (52.6) | ||
Investing activities | ||||||
Additions to property, plant and equipment | (35.0) | (208.2) | ||||
Net cash used in investing activities | $ | (35.0) | $ | (208.2) | ||
Financing activities | ||||||
Proceeds from borrowings — revolving credit facility | 1,077.7 | 1,084.8 | ||||
Repayments of borrowings — revolving credit facility | (899.3) | (1,101.0) | ||||
Proceeds from borrowings — MRL revolving credit agreement | 32.0 | 37.2 | ||||
Repayments of borrowings — MRL revolving credit agreement | (38.6) | (18.7) | ||||
Proceeds from borrowings — senior notes | 200.0 | 325.0 | ||||
Repayments of borrowings — senior notes | (229.0) | (121.0) | ||||
Proceeds from inventory financing | 408.1 | 791.2 | ||||
Payments on inventory financing | (462.6) | (796.6) | ||||
Proceeds from other financing obligations | — | 95.8 | ||||
Payments on other financing obligations | (25.9) | (28.5) | ||||
Net cash provided by financing activities | $ | 62.4 | $ | 268.2 | ||
Net increase (decrease) in cash, cash equivalents and restricted cash | $ | (0.1) | $ | 7.4 | ||
Cash, cash equivalents and restricted cash at beginning of period | $ | 14.7 | $ | 35.2 | ||
Cash, cash equivalents and restricted cash at end of period | $ | 14.6 | $ | 42.6 | ||
Cash and cash equivalents | $ | 7.0 | $ | 36.0 | ||
Restricted cash | $ | 7.6 | $ | 6.6 | ||
Supplemental disclosure of non-cash investing activities | ||||||
Non-cash property, plant and equipment additions | $ | 26.1 | $ | 41.7 | ||
CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. | ||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
(Unaudited) | (Unaudited) | |||||||||||
Reconciliation of Net loss to EBITDA, Adjusted EBITDA and Distributable Cash Flow: | ||||||||||||
Net loss | $ | (39.1) | $ | (22.3) | $ | (80.7) | $ | (3.7) | ||||
Add: | ||||||||||||
Interest expense | 56.8 | 55.8 | 117.6 | 105.0 | ||||||||
Depreciation and amortization | 36.4 | 33.2 | 72.4 | 62.7 | ||||||||
Income tax expense | 0.5 | 0.4 | 0.7 | 0.9 | ||||||||
EBITDA | $ | 54.6 | $ | 67.1 | $ | 110.0 | $ | 164.9 | ||||
Add: | ||||||||||||
LCM / LIFO (gain) loss | $ | (9.5) | $ | (5.8) | $ | (0.5) | $ | 13.9 | ||||
Unrealized gain on derivative instruments | (3.0) | (14.1) | (38.7) | (55.1) | ||||||||
Debt extinguishment costs | 0.1 | 5.2 | 0.3 | 5.2 | ||||||||
Amortization of turnaround costs | 9.5 | 9.6 | 18.9 | 17.3 | ||||||||
RINs mark-to-market (gain) loss | 12.2 | 3.6 | (58.9) | (42.5) | ||||||||
Equity-based compensation and other items | 4.7 | (1.9) | (2.6) | 7.2 | ||||||||
Other non-recurring (income) expenses (1) | (0.8) | 3.6 | 60.0 | 33.1 | ||||||||
Noncontrolling interest adjustments | (1.0) | 0.8 | (0.1) | 1.4 | ||||||||
Adjusted EBITDA | $ | 66.8 | $ | 68.1 | $ | 88.4 | $ | 145.4 | ||||
Less: | ||||||||||||
Replacement and environmental capital expenditures (2) | $ | 10.7 | $ | 14.5 | $ | 27.4 | $ | 31.7 | ||||
Cash interest expense (3) | 54.8 | 54.6 | 113.6 | 102.3 | ||||||||
Turnaround costs | 9.7 | 6.0 | 15.2 | 13.1 | ||||||||
Income tax expense | 0.5 | 0.4 | 0.7 | 0.9 | ||||||||
Distributable Cash Flow | $ | (8.9) | $ | (7.4) | $ | (68.5) | $ | (2.6) | ||||
__________________
(1) | For the six months ended June 30, 2024, other non-recurring expenses included a |
(2) | Replacement capital expenditures are defined as those capital expenditures which do not increase operating capacity or reduce operating costs and exclude turnaround costs. Environmental capital expenditures include asset additions to meet or exceed environmental and operating regulations. |
(3) | Represents consolidated interest expense less non-cash interest expense. |
CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. | |||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||
(Unaudited) | |||||||||||||
Reconciliation of Segment Gross Profit (Loss) to Segment Adjusted Gross Profit: | |||||||||||||
Specialty Products and Solution segment gross profit | $ | 39.1 | $ | 45.3 | $ | 124.4 | $ | 155.2 | |||||
LCM/LIFO inventory (gain) loss | 0.7 | 1.5 | (2.9) | 2.7 | |||||||||
RINs mark to market (gain) loss | 8.4 | 2.4 | (39.5) | (25.7) | |||||||||
Depreciation and amortization | 17.8 | 19.1 | 35.4 | 34.9 | |||||||||
Specialty Products and Solutions segment Adjusted gross profit | $ | 66.0 | $ | 68.3 | $ | 117.4 | $ | 167.1 | |||||
Performance Brands segment gross profit | $ | 25.1 | $ | 21.4 | $ | 47.4 | $ | 45.0 | |||||
LCM/LIFO inventory (gain) loss | (0.3) | 0.6 | (0.1) | 2.1 | |||||||||
Other adjustments (1) | — | — | — | (5.0) | |||||||||
Depreciation and amortization | 0.6 | 0.6 | 1.3 | 1.3 | |||||||||
Performance Brands segment Adjusted gross profit | $ | 25.4 | $ | 22.6 | $ | 48.6 | $ | 43.4 | |||||
$ | (0.4) | $ | 4.8 | $ | (29.5) | $ | (32.1) | ||||||
LCM/LIFO inventory (gain) loss | (10.0) | (7.9) | 2.4 | 9.1 | |||||||||
Loss on firm purchase commitments | — | — | 8.5 | 28.4 | |||||||||
RINs mark to market (gain) loss | 3.8 | 1.4 | (19.4) | (13.9) | |||||||||
Depreciation and amortization | 25.4 | 21.0 | 50.8 | 39.4 | |||||||||
$ | 18.8 | $ | 19.3 | $ | 12.8 | $ | 30.9 | ||||||
Reported Specialty Products and Solutions segment gross profit per barrel | $ | 6.71 | $ | 8.55 | $ | 11.07 | $ | 14.82 | |||||
LCM/LIFO inventory (gain) loss per barrel | 0.12 | 0.28 | (0.26) | 0.26 | |||||||||
RINs mark to market (gain) loss per barrel | 1.44 | 0.45 | (3.52) | (2.45) | |||||||||
Depreciation and amortization per barrel | 3.05 | 3.62 | 3.16 | 3.32 | |||||||||
Specialty Products and Solutions segment Adjusted gross profit per barrel | $ | 11.32 | $ | 12.90 | $ | 10.45 | $ | 15.95 | |||||
Reported Performance Brands segment gross profit per barrel | $ | 141.01 | $ | 153.96 | $ | 147.20 | $ | 169.17 | |||||
LCM/LIFO inventory (gain) loss per barrel | (1.69) | 4.32 | (0.31) | 7.89 | |||||||||
Other adjustments per barrel | — | — | — | (18.80) | |||||||||
Depreciation and amortization per barrel | 3.38 | 4.31 | 4.04 | 4.90 | |||||||||
Performance Brands segment Adjusted gross profit per barrel | $ | 142.70 | $ | 162.59 | $ | 150.93 | $ | 163.16 | |||||
Reported | $ | (0.18) | $ | 2.70 | $ | (6.92) | $ | (9.47) | |||||
LCM/LIFO inventory (gain) loss per barrel | (4.54) | (4.44) | 0.56 | 2.68 | |||||||||
Loss on firm purchase commitments per barrel | — | — | 2.00 | 8.38 | |||||||||
RINs mark to market (gain) loss per barrel | 1.72 | 0.79 | (4.55) | (4.10) | |||||||||
Depreciation and amortization per barrel | 11.53 | 11.80 | 11.91 | 11.63 | |||||||||
$ | 8.53 | $ | 10.85 | $ | 3.00 | $ | 9.12 | ||||||
Specialty Products and Solutions Adjusted EBITDA | $ | 65.8 | $ | 61.0 | $ | 107.6 | $ | 137.0 | |||||
Specialty Products and Solutions sales | 746.2 | 684.1 | 1,427.8 | 1,422.8 | |||||||||
Specialty Products and Solutions Adjusted EBITDA margin | 8.8 | % | 8.9 | % | 7.5 | % | 9.6 | % | |||||
__________________
(1) | For the six months ended June 30, 2023, other adjustments for the Performance Brands segment included a |
View original content:https://www.prnewswire.com/news-releases/calumet-reports-second-quarter-2024-results-302218775.html
SOURCE Calumet, Inc.
FAQ
What was Calumet's net loss for Q2 2024?
How much SAF did Montana Renewables produce in Q2 2024?
What was Calumet's Adjusted EBITDA for Q2 2024?
How did Calumet's Specialty Products and Solutions segment perform in Q2 2024?
What major structural change did Calumet complete in 2024?
